- Home
- ATXS vs AIRJ Comparison
ATXS vs AIRJ Comparison
Compare ATXS & AIRJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- AIRJ
- Stock Information
- Founded
- ATXS 2008
- AIRJ N/A
- Country
- ATXS United States
- AIRJ United States
- Employees
- ATXS N/A
- AIRJ N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- AIRJ
- Sector
- ATXS Health Care
- AIRJ
- Exchange
- ATXS Nasdaq
- AIRJ NYSE
- Market Cap
- ATXS 401.2M
- AIRJ 272.7M
- IPO Year
- ATXS 2015
- AIRJ N/A
- Fundamental
- Price
- ATXS $5.34
- AIRJ $4.61
- Analyst Decision
- ATXS Strong Buy
- AIRJ Strong Buy
- Analyst Count
- ATXS 5
- AIRJ 1
- Target Price
- ATXS $26.60
- AIRJ $12.00
- AVG Volume (30 Days)
- ATXS 276.5K
- AIRJ 80.1K
- Earning Date
- ATXS 03-11-2025
- AIRJ 03-25-2025
- Dividend Yield
- ATXS N/A
- AIRJ N/A
- EPS Growth
- ATXS N/A
- AIRJ N/A
- EPS
- ATXS N/A
- AIRJ 4.03
- Revenue
- ATXS N/A
- AIRJ N/A
- Revenue This Year
- ATXS N/A
- AIRJ N/A
- Revenue Next Year
- ATXS N/A
- AIRJ N/A
- P/E Ratio
- ATXS N/A
- AIRJ $1.14
- Revenue Growth
- ATXS N/A
- AIRJ N/A
- 52 Week Low
- ATXS $5.29
- AIRJ $4.41
- 52 Week High
- ATXS $14.04
- AIRJ $21.78
- Technical
- Relative Strength Index (RSI)
- ATXS 28.85
- AIRJ 21.83
- Support Level
- ATXS $5.89
- AIRJ $4.75
- Resistance Level
- ATXS $6.52
- AIRJ $7.93
- Average True Range (ATR)
- ATXS 0.40
- AIRJ 0.71
- MACD
- ATXS -0.06
- AIRJ -0.33
- Stochastic Oscillator
- ATXS 2.50
- AIRJ 5.14
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About AIRJ MONTANA TECHNOLOGIES CORP
AirJoule Technologies Corp is the developer of AirJoule, an atmospheric water harvesting technology that provides efficient and sustainable air dehumidification and pure water from air. AirJoule can also enable transformative HVAC products to help customers save money on their energy bills while reducing environmental impact.